NCT02594215 2022-06-30
Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
National Institutes of Health Clinical Center (CC)
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)